康华医疗2024 年报

廣東康華醫療集團股份有限公司 Guangdong Kanghua Healthcare Group Co., Ltd.* ( 前稱廣東康華醫療股份有限公司 )(Formerly known as Guangdong Kanghua Healthcare Co., Ltd.)( 於中華人民共和國註冊成立的股份有限公司 )(A joint stock company incorporated in the People's Republic of China with limited liability) 股份代號 Stock Code:3689* 僅供識別 For identification purposes only 2024A N N U A LR E P O R T年 報 Contents目錄 2Corporate Information公司資料4Financial Highlights財務概覽6The Chief Executive Officer’s Statement行政總裁報告12Management Discussion and Analysis管理層討論及分析56Report of the Board董事會報告80Report of the Supervisory Committee監事會報告81Corporate Governance Report企業管治報告105Environmental, Social and Governance Report環境、社會及管治報告154Directors, Supervisors and Senior Management董事、監事及高級管理層166Independent Auditor’s Report獨立核數師報告175Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表176Consolidated Statement of Financial Position綜合財務狀況表178Consolidated Statement of Changes in Equity綜合權益變動表179Consolidated Statement of Cash Flows綜合現金流量表181Notes to the Consolidated Financial Statements綜合財務報表附註293Financial Summary財務概要294Definitions釋義 Corporate Information公司資料 董事會 BOARD OF DIRECTORS 執行董事 Executive Directors 王君揚先生（主席）陳旺枝先生（行政總裁）王偉雄先生（副主席）王愛勤女士 Mr. Wang Junyang(Chairman)Mr. Chen Wangzhi(Chief Executive Officer)Mr. Wong Wai Hung(Vice Chairman)Ms. Wang Aiqin 非執行董事 Non-executive Director 呂玉波先生 Mr. Lv Yubo 獨立非執行董事 Independent Non-executive Directors 楊銘澧先生陳可冀醫生陳星能先生 Mr. Yeung Ming LaiDr. Chen KejiMr. Chan Sing Nun 審核委員會 Audit Committee 陳星能先生（主席）陳可冀醫生楊銘澧先生 Mr. Chan Sing Nun(Chairman)Dr. Chen KejiMr. Yeung Ming Lai 薪酬委員會 Remuneration Committee 陳星能先生（主席）王愛勤女士楊銘澧先生 Mr. Chan Sing Nun(Chairman)Ms. Wang AiqinMr. Yeung Ming Lai 提名委員會 Nomination Committee 王君揚先生（主席）陳可冀醫生楊銘澧先生 Mr. Wang Junyang(Chairman)Dr. Chen KejiMr. Yeung Ming Lai 監事會 SUPERVISORY COMMITTEE 陳少明先生（主席）王少鋒先生岳春陽先生 Mr. Chen Shaoming(Chairman)Mr. Wang ShaofengMr. Yue Chunyang 聯席公司秘書 JOINT COMPANY SECRETARIES 黃偉恒先生周慶齡女士 Mr. Wong Wai Hang RickyMs. Chau Hing Ling 董事會秘書 SECRETARY TO THE BOARD 黃偉恒先生 Mr. Wong Wai Hang Ricky 授權代表 AUTHORISED REPRESENTATIVES 王偉雄先生黃偉恒先生 Mr. Wong Wai HungMr. Wong Wai Hang Ricky 核數師 AUDITOR 天職香港會計師事務所有限公司執業會計師註冊公眾利益實體核數師 Baker Tilly Hong Kong LimitedCertified Public AccountantsRegistered Public Interest Entity Auditor 香港法律顧問 LEGAL ADVISERS AS TO HONG KONG LAWS 偉凱律師事務所 White & Case 中國法律顧問通商律師事務所 LEGAL ADVISERS AS TO PRC LAWSCommerce & Finance Law Offices 註冊辦事處 REGISTERED OFFICE 中國廣東省東莞市南城街道東莞康華醫院門診一區3樓 3/F, Outpatient Zone OneDongguan Kanghua HospitalNancheng Street RoadDongguanGuangdong ProvincePRC 中國總部 HEAD OFFICE IN THE PRC 中國廣東省東莞市東莞大道1000號 1000 Dongguan AvenueDongguanGuangdong ProvincePRC 香港主要營業地點 PRINCIPAL PLACE OF BUSINESS IN HONG KONG 香港新界葵芳興芳路223號新都會廣場第二座3207室 Unit 3207, Metroplaza Tower 2223 Hing Fong RoadKwai Fong, New TerritoriesHong Kong H股證券登記處 H SHARE REGISTRAR 香港中央證券登記有限公司香港灣仔皇后大道東183號合和中心17樓1712–1716號舖 Computershare Hong Kong Investor Services LimitedShops 1712–1716, 17th FloorHopewell Centre183 Queen’s Road EastWanchaiHong Kong 股份代號 STOCK CODE 3689 3689 公司網站http://www.kanghuagp.com COMPANY’S WEBSITE http://www.kanghuagp.com Financial Highlights財務概覽 KEY FINANCIAL PERFORMANCE主要財務表現 經 調 整EBITDA為 除 銀 行 及 其 他 利 息 收 入、利 息 開 支、稅 項、折 舊 及 攤 銷、公 平 值 收益╱虧損及按公平值計入損益（「按公平值計入損益」）的金融資產投資收入及匯兌收益╱虧損淨額。 #Adjusted EBITDA is earnings before accounting for bank and other interest income,interest expense, taxes, depreciation and amortisation, fair value gain/loss andinvestment income from financial assets at fair value through profit or loss (“FVTPL”)and net exchange gain/loss. The Chief Executive Ofcer’s Statement行政總裁報告The Chief Executive Officer’s Statement行政總裁報告 Chen Wangzhi陳旺枝 Chief Executive Officer行政總裁 In 2024, the global situation was complex and rapidlyevolving. Economic development showed a diverse andfragmented landscape under the intertwined influenceof technological advancements and geopolitical factors.The continued acceleration of digital transformation hasalso intensified competition and innovation pressureamong industries. Under such environment, themedical healthcare industry is undergoing changes atan unprecedent scale. Amidst this wave of challengesand opportunities, under the leadership of the Board,all employees of the Group have closely followed ourdevelopment strategy of “Precision healthcare, EfficientManagement and Sincere Service”, committed to steadyprogress with determination, we navigate our missionto save lives with professionalism as our oar andconviction as our sail, delivering a track record of solidand impactful achievements. 二零二四年，全球局勢複雜多變，經濟發展在科技浪潮與地緣政治的交織影響下，呈現出多元分化的態勢。數字化轉型持續加速，也加劇了行業間的競爭與創新壓力。在這樣的大環境下，醫療行業正經歷著深刻變革。在這充滿挑戰與機遇的浪潮中，本集團全體員工在董事會的領導下，緊緊圍繞三精管理即「精準醫療、精益管理、精誠服務」的發展戰略，堅持穩中求進，奮力拼搏，以專業為槳，以信念為帆，在救死扶傷的使命航道上，留下了或深或淺卻堅實有力的奮鬥航跡。 The Chief Executive Ofcer’s Statement行政總裁報告 致股東： Dear Shareholders: 本人謹代表本公司衷心感謝全體股東及社會各界其他利益相關人士對本集團的持續支持。 On behalf of the Company, I sincerely exp